The Board has granted a 60 percent evaluation for the veteran's Type I diabetes mellitus with nephropathy and diabetic retinopathy, which was previously evaluated as 20 percent disabling.
The deciding factor: The veteran's diabetes mellitus is manifested by no more than the use of an insulin pump, a restricted diet, and regulation of activities; monthly or less frequent visits to a diabetic care provider; post-operative bilateral diabetic background retinopathy and right eye macular edema residuals with bilateral corrected 20/20 visual acuity and no visual field deficits; diabetic peripheral neuropathy of the upper and lower extremities; and no current evidence of nephropathy. Given these findings, the disability picture most closely approximates the criteria for a 60 percent evaluation under Diagnostic Code 7913.
- Claimed conditions
- Type I diabetes mellitus, diabetic retinopathy, diabetic peripheral neuropathy
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- July 16, 2008
- Citation
- 0823600
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0823600.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board has remanded the claims for asthma, hypertension with residuals including stroke, DM II, bilateral amputation of all toes, and diabetic neuropathy to obtain VA medical opinions regarding the nature and etiology of these conditions.,The Board also remanded the claim for ED as it is inextricably intertwined with the DM II claim.
- Granted
The Board has granted DIC benefits based on service connection for the cause of the Veteran's death, finding that his service-connected prostate cancer and its treatment caused his death due to side effects from Zytiga.
- Denied
The Veteran's initial ratings for diabetes and diabetic retinopathy were denied. The Board found that the current ratings adequately reflect the severity of his symptoms, including his need for eye injections to treat his diabetic retinopathy.
- Granted
The Veteran's lumbar radiculopathy and diabetic peripheral neuropathy of the right lower extremity are rated at 20 percent effective November 6, 2024.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.